It targets proinflammatory interleukin (IL)-1 and IL-18 pathways, significantly alleviating inflammation and steatosis while restoring normal levels of alanine transaminase (ALT), aspartate transaminase (AST), and maintaining a proper balance between reactive oxygen species and antioxidant enzymes (38). The gene discussed is GPT; the disease is steatosis.